| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |